[1]
Baughman, R.P. et al. 2016. Infliximab for chronic cutaneous sarcoidosis: a subset analysis from a double-blind randomized clinical trial. Sarcoidosis, Vasculitis and Diffuse Lung Diseases. 32, 4 (Jan. 2016), 289–295.